Outcome of Rhabdomyosarcoma in First Year of Life: Children’s Cancer Hospital 57357 Egypt

Table 1

Low risk protocol roadmap.

Weeks	1	2	3	4	5	6	7	8	9	10	11	12	13
	VAC	V	V	VAC	V	V	VAC	V	V	AC	**	**	VA
Weeks	14	15	16	17	18	19	20	21	22	23	24	25	26
	V	V	VA	V	V	VA	V	V	A	**	**	VA	V
Weeks	27	28	29	30	31	32	33	34	35	36	37	38	39
	V	VA	V	V	VA	V	V	A	**	**	VA	V	V
Weeks	40	41	42	43	44	45	46	47
	VA	V	V	VA	V	V	VA	**

Vincristine (V): 1.5 mg/m² (max. 2 mg) IV push.
Actinomycin (A): 0.045 mg/kg (max. 2.5 mg) IV push.
Cyclophosphamide (C): 1.2 gm/m² IV infusion over 60 min with hydration and MESNA.
**No chemotherapy and the time of reevaluation (at weeks 12, 24, 36, and 47 end of therapy).